Quest Diagnostics
Presence
Quest Diagnostics is one of the...
Quest Diagnostics is a company listed under the stock ticker DGX (US).
Acquisition, funding and merger involving Quest Diagnostics.
- Quest Diagnostics has announced the acquisition of Haystack Oncology (posted on May 2 2023).
Executives
View the org chart displaying its 33 main executives
Most searched biographies at Quest Diagnostics
- James Davis, Chief Executive Officer and Chairman of the Board
- Gail Wilensky, Director
- Gary Pfeiffer, Director
Popular executive movements at Quest Diagnostics
- Yuri Fesko has joined the company as Senior Vice President and Chief Medical Officer (posted on December 21 2023).
Create your alert
to follow the executive moves at Quest Diagnostics.
Healthcare
Quest Diagnostics has 1,818 competitors including Siemens Healthineers (Germany), IQVIA (United States (USA)) and Saint Francis Health System (United States (USA)).
Popular M&A news in Healthcare
- Xaira Therapeutics becomes a unicorn with its fundraising of $1,000 Million. (posted on April 25 2024).
- Two Chairs has just announced a $72 Million fundraising (posted on April 18 2024).
- Grow Therapy has just announced a $88 Million fundraising (posted on April 12 2024).
Popular contacts in Healthcare
News
Press releases by Quest Diagnostics
- Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
- Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
- Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
- Quest Diagnostics Newsroom - News ReleasesBack ButtonSearch IconFilter Icon
- Quest Diagnostics Facts at a Glance: Facts & FiguresBack ButtonSearch IconFilter Icon
- Quest Diagnostics and Instacart Collaborate to Reduce Food Insecurity Across the United States with Integrated Patient Health Coaching and Nutritious Grocery Delivery
- Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
- Quest Diagnostics Newsroom - AwardsBack ButtonSearch IconFilter Icon
- Quest Diagnostics Debuts MelaNodal Predict™ Test, Personalizing Melanoma Risk Prediction to Help Patients Forgo Invasive Surgery
- First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
- View more press releases Close
Social media about Quest Diagnostics
- Quest Diagnostics on Wikipedia, Google News & Yahoo Finance
- Quest Diagnostics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including James Davis 
Call Quest Diagnostics at +1 973...
